Austar Lifesciences Limited (HKG:6118)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7200
0.00 (0.00%)
Sep 30, 2026, 3:52 PM HKT

Austar Lifesciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6131,5311,5001,7642,1572,015
Revenue Growth
5.39%2.02%-14.93%-18.23%7.04%55.48%
Gross Profit
292.28293.27301.22336.05488.8479.01
Operating Income
42.4443.134.77-41.21122.79116.97
Net Income
17.2733.8116.08-113.4787.46277.3
Earnings Per Share
0.030.070.03-0.220.170.54
EPS Growth
-48.92%110.25%---68.40%800.00%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Life Science Equipment and Consumables
333.37329.65346.16321.78391.81428.39
Integrated Process and Packaging Equipment & Systems
1,1171,006821.33984.85--
Consulting,digitalization and Construction
529.36509.58611.42732.65--
Inter-Segment
-366.55-314.94-278.51-275.54-306.82-164.8
Total
1,6131,5311,5001,7642,1572,015

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
209.69227.39167.81173.77148.13219.74
Total Debt
268.24343.68401.95496.2336.55155.22
Net Cash (Debt)
-58.55-116.28-234.15-322.43-188.4264.52
Net Cash Growth
------36.53%
Net Cash Per Share
-0.11-0.23-0.46-0.63-0.370.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
181.45132.198.81-62.65-37.93-103.45
Capital Expenditures
-33.58-23.1-20.49-69.24-117.11-100.57
Free Cash Flow
147.8710978.31-131.88-155.04-204.02
Free Cash Flow Growth
35.66%39.18%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
18.12%19.16%20.08%19.05%22.66%23.77%
Operating Margin
2.63%2.82%2.32%-2.34%5.69%5.80%
Pretax Margin
2.20%3.14%1.41%-1.95%5.54%15.84%
Profit Margin
1.07%2.21%1.07%-6.43%4.06%13.76%
FCF Margin
9.17%7.12%5.22%-7.48%-7.19%-10.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.5111.8517.08-10.4722.71
Forward PE
-4.804.804.804.804.80
P/FCF Ratio
2.163.683.51---
PS Ratio
0.200.260.180.410.433.13